An IQSEC2 Mutation Associated With Intellectual Disability and Autism Results in Decreased Surface AMPA Receptors

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Intellectual disability, autism, and epilepsy are complex neurodevelopmental disorders.
• The IQSEC2 gene and its associated mutations are implicated in these conditions.
• Understanding the molecular basis of IQSEC2 mutations is crucial for developing effective therapies.

Purpose of the Study:

• To elucidate the molecular pathophysiology of the A350V mutation in IQSEC2.
• To identify potential drug targets for treating neurodevelopmental disorders caused by this mutation.

Main Methods:

• Investigated the effect of the A350V mutation on apocalmodulin binding to IQSEC2.
• Assessed the guanine nucleotide exchange factor (GEF) activity of mutated IQSEC2 and its impact on Arf6.
• Utilized a CRISPR-generated mouse model to study the mutation's effects on hippocampal GluA2 AMPA receptor surface expression and synaptic transmission.
• Evaluated behavioral phenotypes in mutant mice, including activity levels, social behavior, and learning.

Main Results:

• The A350V mutation impairs apocalmodulin binding to IQSEC2.
• This mutation leads to constitutive activation of IQSEC2's GEF activity, increasing active Arf6 production.
• Mutant mice exhibit reduced surface expression of GluA2 AMPA receptors and impaired basal synaptic transmission in the hippocampus.
• A350V IQSEC2 mutant mice display increased activity, abnormal social behavior, and learning deficits.

Conclusions:

• The A350V mutation in IQSEC2 disrupts protein interactions and signaling pathways, leading to neurophysiological and behavioral abnormalities.
• These findings provide a mechanistic model for IQSEC2-related neurodevelopmental disorders.
• The study highlights potential therapeutic targets for a personalized, precision medicine approach to these conditions.